Acm Research, INC Form 4 insider transactions

Director Tracy Liu acquired 20,000 stock options in ACM Research, Inc. on August 12, 2024.

Director Haiping Dun of ACM Research, Inc. acquired 20,000 stock options on August 12, 2024, exercisable prior to the 2025 annual meeting.

Director Chenming Hu of ACM Research, Inc. was granted 20,000 stock options on August 12, 2024, exercisable prior to the 2025 annual meeting.

Director Haiping Dun exercised stock options in ACM Research, resulting in the acquisition and disposal of shares to cover the exercise price.

Director Haiping Dun gifted 100,000 shares of Class A Common Stock and 300,000 shares of Class B Common Stock to the Dun Family GST Trust on June 27, 2024.

Jian Wang, a key executive at ACM Research, recently exercised stock options and sold a portion of the acquired shares under a pre-arranged trading plan.

Jian Wang, a key executive at ACM Research, recently exercised stock options and sold 60,000 shares of Class A Common Stock, according to a Form 4 filing with the SEC.

Mark McKechnie, CFO of ACM Research, exercised stock options and sold shares of Class A Common Stock on June 6, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Haiping Dun, a director at ACM Research, sold 19,239 shares of Class A Common Stock at a weighted average price of $22.63 on May 29, 2024, under a pre-arranged 10b5-1 trading plan.

David H. Wang, a director at ACM Research, sold a significant number of shares under a pre-arranged 10b5-1 trading plan.

David H. Wang, CEO of ACM Research, sold 90,000 shares of Class A Common Stock on May 22, 2024, at a weighted average price of $22.81 per share, according to a Form 4 filing with the SEC.

Haiping Dun, a director at ACM Research, Inc., sold 15,000 shares of Class A Common Stock on May 22, 2024, under a pre-arranged Rule 10b5-1 trading plan.

ACM Research CEO David Wang exercised stock options for 180,000 shares of Class A Common Stock on May 14, 2024, resulting in a net acquisition of 176,090 shares after withholding for exercise price payment.

Haiping Dun, a director at ACM Research, exercised stock options to acquire 34,239 shares of Class A Common Stock on May 14, 2024.

ACM Research CEO David Wang sold shares of Class A Common Stock on March 14, 2024, under a pre-arranged 10b5-1 trading plan.

Director Haiping Dun of ACM Research, Inc. sold shares of Class A Common Stock on March 14, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Sotheara Cheav, a Senior Vice President at ACM Research, sold shares of Class A Common Stock under a pre-arranged 10b5-1 trading plan.

Haiping Dun, a director at ACM Research, sold 15,000 shares of Class A Common Stock on March 8, 2024, at a weighted average price of $30.36.

ACM Research CEO David H. Wang sold 90,000 shares of Class A Common Stock on March 8, 2024, at weighted average prices of $30.36 and $30.35, respectively, under a pre-arranged 10b5-1 trading plan.

ACM Research CEO David H. Wang exercised stock options on March 1, 2024, acquiring shares of Class A Common Stock.

Director Haiping Dun exercised stock options for 35,000 shares of ACM Research, Inc. Class A Common Stock on March 1, 2024.

Lisa Feng, CFO of ACM Research (Shanghai), exercised stock options and sold shares of Class A Common Stock on February 28, 2024.

Director Tracy Liu of ACM Research, Inc. exercised stock options and sold shares of Class A Common Stock on February 28, 2024, according to a Form 4 filing.